Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
AeroBPD
2 other identifiers
observational
165
1 country
1
Brief Summary
Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 22, 2019
CompletedFirst Submitted
Initial submission to the registry
September 24, 2019
CompletedFirst Posted
Study publicly available on registry
September 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 6, 2026
May 1, 2026
6.4 years
September 24, 2019
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Respiratory Morbidity
maximum symptom days in the prior 2 weeks assessed at completion of home sampling visits ( Units: days scale: 0-14 days with symptoms, higher is worse
2 weeks
Lung Function
Spirometry (FEV1 percent predicted) Units: percent Scale: continuous integers, higher is better
1 yr
Secondary Outcomes (9)
Lung function
1 year
Lung function
1 year
Lung function
1 year
Lung function
1 year
Lung function
1 year
- +4 more secondary outcomes
Eligibility Criteria
Children 6-12 years with BPD in MA
You may qualify if:
- children 6-12 yrs old
- born \<32 wks gestational age
- diagnosis of BPD or \> 28 days of oxygen or respiratory support
You may not qualify if:
- major airway or chest surgery
- physical or mental impairment that will prevent from doing spirometry
- plans to move out of state within the next 9 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Childrens Hospital
Boston, Massachusetts, 02115, United States
Related Publications (1)
Ruran HB, Adamkiewicz G, Cunningham A, Petty CR, Greco KF, Gunnlaugsson S, Stamatiadis N, Sierra G, Vallarino J, Alvarez M, Hayden LP, Sheils CA, Weller E, Phipatanakul W, Gaffin JM. Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic. BMJ Open Respir Res. 2021 Jun;8(1):e000915. doi: 10.1136/bmjresp-2021-000915.
PMID: 34193433DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Gaffin, MD. MMSc.
Boston Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Assistant Professor of Pediatrics
Study Record Dates
First Submitted
September 24, 2019
First Posted
September 27, 2019
Study Start
July 22, 2019
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share